0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.24%
Positive revenue growth while 0425.HK is negative. John Neff might see a notable competitive edge here.
9.27%
Gross profit growth above 1.5x 0425.HK's 3.90%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-4.45%
Negative EBIT growth while 0425.HK is at 5.92%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.45%
Negative operating income growth while 0425.HK is at 5.92%. Joel Greenblatt would press for urgent turnaround measures.
23.51%
Net income growth comparable to 0425.HK's 25.13%. Walter Schloss might see both following similar market or cost trajectories.
21.43%
EPS growth at 75-90% of 0425.HK's 24.14%. Bill Ackman would push for improved profitability or share repurchases to catch up.
21.43%
Diluted EPS growth at 75-90% of 0425.HK's 24.14%. Bill Ackman would expect further improvements in net income or share count reduction.
1.69%
Share count expansion well above 0425.HK's 0.93%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.59%
Diluted share count expanding well above 0425.HK's 0.93%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
19.78%
OCF growth 1.25-1.5x 0425.HK's 14.11%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
25.16%
FCF growth under 50% of 0425.HK's 150.73%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
21014.84%
10Y revenue/share CAGR above 1.5x 0425.HK's 548.39%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
24.65%
5Y revenue/share CAGR under 50% of 0425.HK's 108.14%. Michael Burry would suspect a significant competitive gap or product weakness.
-3.39%
Negative 3Y CAGR while 0425.HK stands at 64.36%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-9466.85%
Negative 10Y OCF/share CAGR while 0425.HK stands at 434.47%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-5313.50%
Negative 5Y OCF/share CAGR while 0425.HK is at 115.42%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1349.92%
Negative 3Y OCF/share CAGR while 0425.HK stands at 338.15%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
23.83%
Below 50% of 0425.HK's 336.51%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-22.39%
Negative 5Y net income/share CAGR while 0425.HK is 89.61%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
13.82%
Below 50% of 0425.HK's 57.73%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
95.36%
5Y equity/share CAGR above 1.5x 0425.HK's 62.94%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
40.98%
3Y equity/share CAGR 1.25-1.5x 0425.HK's 34.64%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
93.73%
Below 50% of 0425.HK's 320.86%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
84.64%
3Y dividend/share CAGR above 1.5x 0425.HK's 51.64%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
47.11%
AR growth well above 0425.HK's 1.16%. Michael Burry fears inflated revenue or higher default risk in the near future.
-21.61%
Inventory is declining while 0425.HK stands at 11.18%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
22.34%
Asset growth above 1.5x 0425.HK's 0.11%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.73%
1.25-1.5x 0425.HK's 3.83%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
1816.96%
We have some new debt while 0425.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
80.16%
We increase R&D while 0425.HK cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
47.97%
SG&A growth well above 0425.HK's 2.92%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.